XBiotech (XBIT) Shares Outstanding (2014 - 2026)
XBiotech (XBIT) posted quarterly Shares Outstanding (Entity) of $30.5 million for Q4 2025, little changed year-over-year from $30.5 million in Q4 2024, and little changed quarter-over-quarter from $30.5 million in Q3 2025.
XBiotech (XBIT) Shares Outstanding (2014 - 2026) Analysis & Trends
XBiotech's Shares Outstanding (Entity) history runs 12 years deep, the most recent figure standing at $30.5 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) changed 0.0% year-over-year to $30.5 million; the TTM figure through Dec 2025 stood at $30.5 million (changed 0.0% YoY), while the FY2025 annual figure was $30.5 million, changed 0.0% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $30.5 million, roughly flat from $30.5 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $30.5 million in Q2 2025, with the low at $30.0 million in Q1 2021.
- The 5-year median for Shares Outstanding (Entity) is $30.4 million (2021), against an average of $30.4 million.
- Peak annual rise in Shares Outstanding (Entity) reached 4.02% in 2021, while the deepest fall reached 17.1% in 2021.
- XBiotech's Shares Outstanding (Entity) stood at $30.4 million in 2021, then changed by 0.0% to $30.4 million in 2022, then decreased by 0.01% to $30.4 million in 2023, then climbed by 0.16% to $30.5 million in 2024, then grew by 0.0% to $30.5 million in 2025.
- Business Quant data shows XBIT's Shares Outstanding (Entity) at $30.5 million in Q4 2025, $30.5 million in Q3 2025, and $30.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 133.61 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 217.35 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 445.06 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 241.70 Mn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | 30.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.49 Mn |
| Dec 31, 2025 | 30.49 Mn |
| Sep 30, 2025 | 30.49 Mn |
| Jun 30, 2025 | 30.49 Mn |
| Mar 31, 2025 | 30.49 Mn |
| Dec 31, 2024 | 30.46 Mn |
| Sep 30, 2024 | 30.47 Mn |
| Jun 30, 2024 | 30.46 Mn |
| Mar 31, 2024 | 30.44 Mn |
| Dec 31, 2023 | 30.44 Mn |
| Sep 30, 2023 | 30.44 Mn |
| Jun 30, 2023 | 30.44 Mn |
| Mar 31, 2023 | 30.44 Mn |
| Dec 31, 2022 | 30.44 Mn |
| Sep 30, 2022 | 30.44 Mn |
| Jun 30, 2022 | 30.44 Mn |
| Mar 31, 2022 | 30.04 Mn |
| Dec 31, 2021 | 30.04 Mn |
| Sep 30, 2021 | 30.34 Mn |
| Jun 30, 2021 | 29.99 Mn |